AURA Aura Biosciences: Company Short-Term Debts

Symbol and logo of brand Aura Biosciences, Inc. (AURA)

The historical price chart for Aura Biosciences, Inc. (AURA) on the GURU.Markets platform reflects debt dynamics, which currently stand at 0.00. This biopharmaceutical business is implementing environmental standards by investing in chemical waste disposal and water purification. Simultaneously, Aura Biosciences, Inc. (AURA) is testing new anti-tumor drugs, although high development costs and a lack of operating leverage are creating a prolonged cash flow deficit.

AURA Aura Biosciences Inc Company Short-Term Loans and Borrowings (07/04/2022 - 11/01/2026)

AURA (Aura Corp): analytical breakdowns and indicator data

- stock price and consensus target price:
Stock Price Aura Biosciences|AURA - Consensus Target
- company stock capitalization data:
Market Capitalization Aura Biosciences, Inc.|AURA - Total Enterprise Value
- business book valuation details:
Net Assets per Single Share Aura Biosciences|AURA - Accounting Value of Company|Market Cap to Net Assets Ratio aurabiosciences.com|AURA - Aggregate Asset Value
- debt and liquidity details:
Total Debt to Capital Aura Biosciences, Inc.|AURA - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity Ratio Aura Biosciences, Inc.|AURA - Company Aggregate Debts|Debt to Book Capitalization Ratio Aura Biosciences, Inc.|AURA - Company Long-Term Loans and Borrowings|Company Short-Term Debts Aura Biosciences|Quick Ratio aurabiosciences.com
- earnings and multiples data:
AURA - Net Profit
Analysis of all company metrics:AURA - Aura Biosciences
Manufactured products of aurabiosciences.com

Professional asset selection begins with an analysis of liquidity and a company's ability to service its current liabilities. This indicator aggregates all financial obligations of the issuer with a maturity horizon of up to twelve months. By examining debt maturing within one year, an investor assesses the efficiency of working capital management. For Aura Biosciences, Inc. (AURA), such expenditures reflect investments in the development of targeted drugs. Successful clinical trials confirm the viability of these expenses in creating a future market advantage.

Competing companies

BeiGene - Company Short-Term Debts|Halozyme Therapeutics, Inc. (HALO) - Company Current Liabilities|RVMD: Company Short-Term Debts|Short-Term Debt Ascentage Pharma Corp (AAPG)|Company Short-Term Debt CG Oncology, Inc.|URGN: Company Short-Term Loans and Borrowings|Company Current Liabilities BCAX (Bicara Therapeutics)|PSNL (Personalis Inc) - Company Short-Term Loans and Borrowings|Company Short-Term Debts ERAS (Erasca Corp)|DCTH - Company Current Liabilities|YMAB: Company Current Liabilities|CADL - Company Short-Term Debts|Accuray (ARAY) - Company Short-Term Debt|SELLAS Life Sciences Group - Company Short-Term Loans and Borrowings|ACTU (Actuate Therapeutics, Inc) - Company Short-Term Debts|Short-Term Debt Citius Oncology Inc CTOR|Company Short-Term Debts HURA|Company Short-Term Debts protaratx.com (TARA)|Fate Therapeutics - Company Current Liabilities|Company Short-Term Debts Aadi Bioscience, Inc. WHWK|TCRX - Company Short-Term Debt|Company Short-Term Loans and Borrowings CSBR (Champions Oncology)|XBIT: Company Short-Term Debts|CEL-SCI (CVM) - Company Short-Term Debts|Company Current Liabilities OSTX|RADX: Company Short-Term Loans and Borrowings|Company Short-Term Debts ARTV|Company Short-Term Debt ANL (adlainortye.com)|Company Short-Term Debts VERU (Veru Inc.)|Short-Term Debt Volume tempesttx.com (TPST)|XLO - Company Short-Term Debt|Short-Term Debt Renovaro Inc.|muraloncology.com (MURA) - Company Short-Term Debt|KAPA - Short-Term Debt Volume|OKUR (OnKure Therapeutics, Inc.) - Company Short-Term Debts|Company Current Liabilities CytoMed (GDTC)|Company Short-Term Debts CRIS|Short-Term Debt Volume apollomicsinc.com|Company Short-Term Debts THAR (Tharimmune Corp)|Advanced Biomed Inc. (ADVB) - Short-Term Debt|GNPX - Company Short-Term Debt|CLDI (Calidi Biotherapeutics) - Company Short-Term Indebtedness|SBFM: Company Short-Term Debts|Company Current Liabilities Xenetic Biosciences, Inc.|SLRX (Salarius) - Company Short-Term Debts|Short-Term Debt Kitov Pharma PPBT|Company Short-Term Debt American Oncology Network (AONC)|Short-Term Debt Volume beigene.com|Checkpoint Therapeutics, Inc. - Company Current Liabilities|Company Short-Term Loans and Borrowings ELEV|iCAD Corp - Company Short-Term Debts|Short-Term Debt Volume Ikena Oncology, Inc. IKNA|Notable Labs, Ltd. (NTBL) - Company Short-Term Debt|Company Short-Term Indebtedness VIRX|MOR (MorphoSys) - Company Short-Term Debts|Company Current Liabilities NAYA Biosciences Inc (NAYA)|Company Current Liabilities AAPGV (Ascentage Pharma Group Ltd)